Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of GBP 113.55 billion. The enterprise value is 154.38 billion.

Market Cap	113.55B
Enterprise Value	154.38B

Important Dates

The last earnings date was Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Jan 23, 2026

Share Statistics

Current Share Class	5.69B
Shares Outstanding	n/a
Shares Change (YoY)	+0.23%
Shares Change (QoQ)	-0.49%
Owned by Insiders (%)	0.03%
Owned by Institutions (%)	66.53%
Float	5.68B

Valuation Ratios

The trailing PE ratio is 19.67 and the forward PE ratio is 8.93.

PE Ratio	19.67
Forward PE	8.93
PS Ratio	2.44
PB Ratio	1.76
P/TBV Ratio	n/a
P/FCF Ratio	16.84
P/OCF Ratio	13.06
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.71, with an EV/FCF ratio of 22.90.

EV / Earnings	26.74
EV / Sales	3.28
EV / EBITDA	7.71
EV / EBIT	10.72
EV / FCF	22.90

Financial Position

The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.78.

Current Ratio	1.16
Quick Ratio	0.80
Debt / Equity	0.78
Debt / EBITDA	2.54
Debt / FCF	7.45
Interest Coverage	7.17

Financial Efficiency

Return on equity (ROE) is 8.89% and return on invested capital (ROIC) is 13.65%.

Return on Equity (ROE)	8.89%
Return on Assets (ROA)	5.68%
Return on Invested Capital (ROIC)	13.65%
Return on Capital Employed (ROCE)	11.20%
Weighted Average Cost of Capital (WACC)	5.58%
Revenue Per Employee	619,949
Profits Per Employee	76,985
Employee Count	81,000
Asset Turnover	0.30
Inventory Turnover	1.41

Taxes

Income Tax	-197.64M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +4.86% in the last 52 weeks. The beta is 0.44, so Pfizer's price volatility has been lower than the market average.

Beta (5Y)	0.44
52-Week Price Change	+4.86%
50-Day Moving Average	26.15
200-Day Moving Average	25.04
Relative Strength Index (RSI)	49.32
Average Volume (20 Days)	104,798

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.06

Income Statement

In the last 12 months, Pfizer had revenue of GBP 46.50 billion and earned 5.77 billion in profits. Earnings per share was 1.01.

Revenue	46.50B
Gross Profit	35.25B
Operating Income	14.24B
Pretax Income	5.59B
Net Income	5.77B
EBITDA	19.11B
EBIT	14.24B
Earnings Per Share (EPS)	1.01

Full Income Statement

Balance Sheet

The company has 10.10 billion in cash and 50.26 billion in debt, giving a net cash position of -40.16 billion.

Cash & Cash Equivalents	10.10B
Total Debt	50.26B
Net Cash	-40.16B
Net Cash Per Share	n/a
Equity (Book Value)	64.47B
Book Value Per Share	11.30
Working Capital	4.39B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.70 billion and capital expenditures -1.95 billion, giving a free cash flow of 6.74 billion.

Operating Cash Flow	8.70B
Capital Expenditures	-1.95B
Free Cash Flow	6.74B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 75.81%, with operating and profit margins of 30.62% and 12.42%.

Gross Margin	75.81%
Operating Margin	30.62%
Pretax Margin	12.02%
Profit Margin	12.42%
EBITDA Margin	41.10%
EBIT Margin	30.62%
FCF Margin	14.50%

Dividends & Yields

This stock pays an annual dividend of 1.29, which amounts to a dividend yield of 4.73%.

Dividend Per Share	1.29
Dividend Yield	4.73%
Dividend Growth (YoY)	-3.37%
Years of Dividend Growth	n/a
Payout Ratio	125.74%
Buyback Yield	-0.23%
Shareholder Yield	4.50%
Earnings Yield	5.08%
FCF Yield	5.94%

Dividend Details

Stock Splits

The last stock split was on July 1, 1999. It was a forward split with a ratio of 3.

Last Split Date	Jul 1, 1999
Split Type	Forward
Split Ratio	3

Scores

Pfizer has an Altman Z-Score of 2.11 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.11
Piotroski F-Score	6